Name (Synonyms) | Correlation |
---|
There is one clinical trial.
The investigators hypothesize that the intake of Omni-Biotic® 10 AAD can reduce the duration of diarrhea in Covid-19 disease. The investigators further hypothesize that Omni-Biotic® 10 AAD can reduce stool frequency, improve stool consistency, improve other gastrointestinal symptoms of Covid-19, reduce disease duration and severity, reduce intestinal inflammation and can improve dysbiosis. The investigators aim to perform a randomized, double blind, placebo-controlled study using telemedicine in patients with Covid-19 disease.
Description: Duration of diarrhea (defined as days with 3 or more loose stools)
Measure: Diarrhea Time: 30 daysDescription: stool evacuations per days
Measure: Stool frequency Time: 30 daysDescription: Stool consistency according to Bristol stool scale for each evacuation, score 1-7, a higher score means a lower stool consistancy
Measure: Stool consistency Time: 30 daysDescription: presence of anorexia, nausea, vomiting, abdominal pain, bloating (yes/no)
Measure: Gastrointestinal symptoms Time: 30 daysDescription: days patients feel sick, are not able to work or are on sick leave
Measure: Duration of Covid-19 disease Time: 30 daysDescription: mild/moderate/severe
Measure: Severity of Covid-19 disease Time: 30 daysDescription: measured by ELISA
Measure: Stool Calprotectin Time: 30 daysDescription: measured by ELISA
Measure: Stool Zonulin Time: 30 daysDescription: 16S RNA sequencing
Measure: Microbiome composition Time: 30 days